Endlyz Therapeutics

• Floriana Licitra

  Director, Research Biology

• Oscar Barba

  Head of Discovery

• John Davis

  Scientific Co-founder

• Richard Wade-Martins

  Scientific Co-founder

• Peter Vangheluwe

  Scientific Co-founder

• Joanna Wolak

  Chief Executive Officer

Sources: endlyz.com, sec.gov

• John Davis

• Richard Wade-Martins

• Peter Vangheluwe

• Joanna Wolak

Sources: endlyz.com

• Joanna Wolak

  Board director

• Craig Fox

  Board director, Operating Partner, Oxford Science Enterprises

• Donmienne Leung

  Board director, Director, AbbVie Ventures

• Laurence Barker

  Board director

• Timothy Edwards

  Chairperson, Independent

• Justian Craig Fox

  Board director

Sources: endlyz.com, sec.gov

• United States

Sources: endlyz.com

• Form D

  US$17.3m, 31 Mar 2026

• Form D

  US$3.3m, 16 Jul 2021

Sources: sec.gov

• Centre for Drug Design and Discovery

• Parkinson's UK

• AbbVie Ventures

• Oxford Science Enterprises

• SV Health Investors’ Dementia Discovery Fund

Sources: endlyz.com

• The Michael J. Fox Foundation for Parkinson's Research

  US$2.2m, 31 Mar 2025

Sources: endlyz.com

• Proteostasis

Sources: endlyz.com